<?xml version="1.0" encoding="UTF-8"?>
<p>For some of the most promising SARS-CoV-2 candidate inhibitors, the estimated binding energy to the HIV-1 protease 4RVJ structure (crystallized in complex with amprenavir) was evaluated (center: x = âˆ’1.935, y = 4.006, z = 48.913, box x = 40, y = 40, z = 30).</p>
